Predictive value of germline BRCA1/2 mutations for neoadjuvant pembrolizumab efficacy in early triple-negative breast cancer: A retrospective multicenter study in Korea

Kim, J. H.; Lee, J.; Ahn, H. K.; Shin, K.; Kim, J.; Shin, J.; Ahn, J. S.; Park, Y. H.

doi:10.1016/j.annonc.2025.08.754

상세 보기

Predictive value of germline BRCA1/2 mutations for neoadjuvant pembrolizumab efficacy in early triple-negative breast cancer: A retrospective multicenter study in Korea

Kim, J. H.;
Lee, J.;
Ahn, H. K.;
Shin, K.;
Kim, J.;
... Ahn, J. S.;
... Park, Y. H.;
외 1명

Citations

WEB OF SCIENCE

0

제목: Predictive value of germline BRCA1/2 mutations for neoadjuvant pembrolizumab efficacy in early triple-negative breast cancer: A retrospective multicenter study in Korea

저자: Kim, J. H.; Lee, J.; Ahn, H. K.; Shin, K.; Kim, J.; Shin, J.; Ahn, J. S.; Park, Y. H.

DOI: 10.1016/j.annonc.2025.08.754

발행일: 2025-09

유형: Meeting Abstract

저널명: Annals of Oncology

권: 36

ScholarWorks@성균관대학교

상세 보기